Wade Hull
Technik-/Wissenschafts-/F&E-Leiter bei CRESCITA THERAPEUTICS INC.
Vermögen: 12 563 $ am 31.05.2024
Aktive Positionen von Wade Hull
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CRESCITA THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2016 | - |
Karriereverlauf von Wade Hull
Ehemalige bekannte Positionen von Wade Hull
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS, INC. | Corporate Officer/Principal | 01.05.1996 | 01.12.1996 |
| NUVO PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
ZARS Pharma, Inc.
 ZARS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZARS Pharma, Inc. develops and distributes drugs. It is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs, primarily for the treatment of pain, using its proprietary drug delivery technologies. The company was founded by Jie Zhang, Theodore H. Stanley, Larry D. Rigby and Michael A. Ashburn in 1996 and is headquartered in Salt Lake City, UT. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.1998 | - |
Ausbildung von Wade Hull
| University of Utah | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Kanada | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| UTAH MEDICAL PRODUCTS, INC. | Health Technology |
| CRESCITA THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
ZARS Pharma, Inc.
ZARS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZARS Pharma, Inc. develops and distributes drugs. It is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs, primarily for the treatment of pain, using its proprietary drug delivery technologies. The company was founded by Jie Zhang, Theodore H. Stanley, Larry D. Rigby and Michael A. Ashburn in 1996 and is headquartered in Salt Lake City, UT. | Health Technology |
Nuvo Pharmaceuticals, Inc.
 Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
